| Thrombolysis in acute myocardial infarction. | |
| | |
MedLine Citation:
|
PMID: 1591557 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Reperfusion of ischaemic myocardium with thrombolytic agents during the early stages of acute myocardial infarction reduces the mortality rate and can limit infarct size with associated sparing of left ventricular function. Effective and safe regimens are now available and in the absence of contraindications thrombolysis should now form part of the standard management acute myocardial infarction. |
| | |
Authors:
|
S R Holmberg |
Related Documents
:
|
21430127 - A novel lead configuration for optimal spatio-temporal detection of intracardiac repola... 7612317 - Assessment of the practicality and safety of thrombolysis with anistreplase given by ge... 7921367 - The role of thrombolytic therapy for acute myocardial infarction. 9594337 - Effects of patency of infarct-related coronary artery on acute outcome in acute myocard... 16630087 - Fragmented left sided qrs in absence of bundle branch block: sign of left ventricular a... 9870197 - Evaluation of a novel bioprosthetic heart valve incorporating anticalcification and ant... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: British journal of hospital medicine Volume: 47 ISSN: 0007-1064 ISO Abbreviation: Br J Hosp Med Publication Date: 1992 Apr 15-May 5 |
Date Detail:
|
Created Date: 1992-06-30 Completed Date: 1992-06-30 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 0171545 Medline TA: Br J Hosp Med Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 572-6, 578-80 Citation Subset: IM |
Affiliation:
|
Royal Sussex County Hospital, Brighton. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anistreplase
/
pharmacology,
therapeutic use Clinical Protocols Humans Myocardial Infarction / drug therapy*, etiology, mortality, physiopathology Recombinant Proteins / pharmacology, therapeutic use Streptokinase / pharmacology, therapeutic use Thrombolytic Therapy* Tissue Plasminogen Activator / pharmacology, therapeutic use Urokinase-Type Plasminogen Activator / pharmacology, therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Recombinant Proteins; 81669-57-0/Anistreplase; EC 3.4.-/Streptokinase; EC 3.4.21.68/Tissue Plasminogen Activator; EC 3.4.21.73/Urokinase-Type Plasminogen Activator |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hip replacement surgery.
Next Document: New treatments in inflammatory bowel disease.